Nanopore Diagnostics, LLC — Form D
Nanopore Diagnostics, LLC of ST. LOUIS, MO, a company, filed a Form D exempt-offering notice with the SEC on 2016-01-19. The offering totals $1.0M, of which $585K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-01-19
- Form: D
- Accession: 0001663608-16-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $585K
- Remaining: $415K
- Minimum investment: $25K
- Investors: 10
- Date of first sale: 2015-10-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-255439
Issuer
- Name: Nanopore Diagnostics, LLC
- CIK: 0001663608
- Entity type: Limited Liability Company
- Jurisdiction: MISSOURI
- Incorporated: 2011
- Address: 4320 FOREST PARK AVENUE, SUITE 304, ST. LOUIS, MO, 63108
- Phone: 341-477-4334
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Christoph Bausch | Director | St. Louis, MO |
| Charles Bolten | Director | St. Louis, MO |
| Thomas Cohen | Executive Officer | St. Louis, MO |
More